RADIORECEPTOR ASSAY FOR QUANTIFYING FK-506 IMMUNOSUPPRESSANT IN WHOLE-BLOOD

被引:0
|
作者
MURTHY, JN
CHEN, YJ
WARTY, VS
VENKATARAMANAN, R
DONNELLY, JG
ZEEVI, A
SOLDIN, SJ
机构
[1] CHILDRENS NATL MED CTR,DEPT LAB MED,111 MICHIGAN AVE NW,WASHINGTON,DC 20010
[2] GEORGE WASHINGTON UNIV,SCH MED,DEPT PATHOL,WASHINGTON,DC 20052
[3] GEORGE WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20052
[4] GEORGE WASHINGTON UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20052
[5] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261
[6] UNIV PITTSBURGH,SCH PHARM,PITTSBURGH,PA 15260
关键词
IMMUNOSUPPRESSIVE DRUGS; FK-506 BINDING PROTEIN; ANTIBIOTICS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We describe a quantitative radioreceptor assay (RRA) for quantifying FK-506 in whole blood. FK-506 extracted from whole blood with a cyclohexyl-sorbent column competes with [H-3]dihydro-FK-506 for binding to a partially purified preparation of FK-506 binding protein (FK-BP). Free and protein-bound FK-506 are separated on LH 20 Sephadex chromatographic columns. We compared the results of this method with those of an enzyme immunoassay that uses a monoclonal antibody: r = 0.97, S(y\x) = 0.039. Between-day precisions (CV) at FK-506 concentrations of 8 and 17-mu-g/L were 9.2% and 8.2%, respectively. Within-run precisions were 5.9%, 8.1%, and 9.4%, respectively, at 4, 8, and 15-mu-g/L. Analytical recovery, evaluated at 5, 10, 15, 20, and 25-mu-g/L for FK-506 added to whole blood, ranged from 98% to 103%. The assay can reliably quantify FK-506 blood concentrations between 1.0 and 25-mu-g/L.
引用
收藏
页码:1307 / 1310
页数:4
相关论文
共 50 条
  • [41] INITIAL EXPERIENCE WITH FK-506 AS AN IMMUNOSUPPRESSANT FOR NONHUMAN PRIMATE RECIPIENTS OF CARDIAC ALLOGRAFTS
    FLAVIN, T
    IVENS, K
    WANG, J
    GUTIERREZ, J
    HOYT, EG
    BILLINGHAM, M
    MORRIS, RE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 531 - 532
  • [42] PHARMACOKINETICS OF FK-506, A NOVEL IMMUNOSUPPRESSANT, AFTER INTRAVENOUS AND ORAL ADMINISTRATIONS TO RATS
    TAKADA, K
    USUDA, H
    OHHASHI, M
    YOSHIKAWA, H
    MURANISHI, S
    TANAKA, H
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (01): : 34 - 42
  • [43] THE EFFECT OF THE IMMUNOSUPPRESSANT FK-506 ON ALTERNATE PATHWAYS OF T-CELL ACTIVATION
    BIERER, BE
    SCHREIBER, SL
    BURAKOFF, SJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (02) : 439 - 445
  • [44] INFLUENCE OF FK-506 ON RENAL BLOOD-FLOW
    UEDA, D
    TAJIMA, A
    OHTAWARA, Y
    ISHIKAWA, A
    NAKANO, M
    USHIYAMA, T
    OHTA, N
    KAWABE, K
    ASO, Y
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3121 - 3122
  • [45] INFLUENCE OF FK-506 ON RENAL BLOOD-FLOW
    UEDA, D
    SUZUKI, K
    KAWABE, K
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) : 2722 - 2723
  • [46] ANTIFUNGAL PROPERTIES OF THE IMMUNOSUPPRESSANT FK-506 - IDENTIFICATION OF AN FK-506-RESPONSIVE YEAST GENE DISTINCT FROM FKB1
    BRIZUELA, L
    CHREBET, G
    BOSTIAN, KA
    PARENT, SA
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) : 4616 - 4626
  • [47] A HIGHLY SENSITIVE METHOD TO ASSAY FK-506 LEVELS IN PLASMA
    TAMURA, K
    KOBAYASHI, M
    HASHIMOTO, K
    KOJIMA, K
    NAGASE, K
    IWASAKI, K
    KAIZU, T
    TANAKA, H
    NIWA, M
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (05) : 23 - 29
  • [48] PREVENTIVE EFFECT OF A NEW IMMUNOSUPPRESSANT FK-506 ON INSULITIS AND DIABETES IN NONOBESE DIABETIC MICE
    MIYAGAWA, J
    YAMAMOTO, K
    HANAFUSA, T
    ITOH, N
    NAKAGAWA, C
    OTSUKA, A
    KATSURA, H
    YAMAGATA, K
    MIYAZAKI, A
    KONO, N
    TARUI, S
    DIABETOLOGIA, 1990, 33 (08) : 503 - 505
  • [49] IMPROVED PROCEDURES FOR ENZYME-IMMUNOASSAY OF TACROLIMUS (FK506) IN WHOLE-BLOOD
    DAMBROSIO, R
    JUSKO, WJ
    STABLER, T
    KOBAYASHI, M
    CLINICAL CHEMISTRY, 1994, 40 (01) : 159 - 160
  • [50] CHEMISTRY OF TRICARBONYL HEMIKETALS AND APPLICATION OF EVANS TECHNOLOGY TO THE TOTAL SYNTHESIS OF THE IMMUNOSUPPRESSANT (-)-FK-506
    JONES, TK
    REAMER, RA
    DESMOND, R
    MILLS, SG
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (08) : 2998 - 3017